HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonella Coniglio Selected Research

Lymphangioleiomyomatosis (Lymphangiomyomatosis)

9/2013Is mTOR inhibition a systemic treatment for tuberous sclerosis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonella Coniglio Research Topics

Disease

2Autism Spectrum Disorder
11/2022 - 01/2019
1Alkalosis
01/2021
1Infections
01/2019
1Neurodevelopmental Disorders
01/2019
1Rhabdomyoma
09/2013
1Skin Manifestations
09/2013
1Tuberous Sclerosis (Bourneville's Disease)
09/2013
1Astrocytoma (Pilocytic Astrocytoma)
09/2013
1Epilepsy (Aura)
09/2013
1Angiomyolipoma
09/2013
1Hamartoma
09/2013
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
09/2013
1Liver Cell Adenoma (Hepatocellular Adenoma)
06/2012
1Autistic Disorder (Autism)
01/2012
1Stroke (Strokes)
04/2011
1Activated Protein C Resistance (APC Resistance)
04/2011

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
11/2022 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2012
1Ion Channels (Ion Channel)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1trans-sodium crocetinate (crocetin)IBA
09/2013
1EverolimusFDA Link
09/2013
1Phenobarbital (Luminal)FDA Link
06/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
04/2011
1factor V LeidenIBA
04/2011
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2011
1Prothrombin (Factor II)IBA
04/2011

Therapy/Procedure

1Therapeutics
01/2021
1Drug Therapy (Chemotherapy)
09/2013